Taysha Gene Therapies, Inc. TSHA Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Taysha Gene Therapies, Inc.’s reported figures.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s enterprise value?
- Taysha Gene Therapies, Inc. (TSHA) reported enterprise value of $1.08B in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s enterprise value changed year-over-year?
- Taysha Gene Therapies, Inc.'s enterprise value increased by 367.9% year-over-year, from $229.99M to $1.08B.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s enterprise value?
- Over 4 years (2021 to 2025), Taysha Gene Therapies, Inc.'s enterprise value has grown at a 46.2% compound annual growth rate (CAGR), from $275.38M to $1.26B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.